ATE308541T1 - 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase - Google Patents
2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthaseInfo
- Publication number
- ATE308541T1 ATE308541T1 AT02793211T AT02793211T ATE308541T1 AT E308541 T1 ATE308541 T1 AT E308541T1 AT 02793211 T AT02793211 T AT 02793211T AT 02793211 T AT02793211 T AT 02793211T AT E308541 T1 ATE308541 T1 AT E308541T1
- Authority
- AT
- Austria
- Prior art keywords
- heteroarylethyl
- synthase
- inducible
- amino
- inhibiters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0114509A FR2832151B1 (fr) | 2001-11-09 | 2001-11-09 | Utilisation de derives de 2-amino-4-heteroarylethyl-thiazoline comme inhibiteurs de no-synthase inductible |
| US35297702P | 2002-01-30 | 2002-01-30 | |
| PCT/FR2002/003809 WO2003040142A1 (fr) | 2001-11-09 | 2002-11-07 | Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE308541T1 true ATE308541T1 (de) | 2005-11-15 |
Family
ID=26213259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02793211T ATE308541T1 (de) | 2001-11-09 | 2002-11-07 | 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6872740B2 (de) |
| EP (1) | EP1446402B1 (de) |
| JP (1) | JP4365681B2 (de) |
| AT (1) | ATE308541T1 (de) |
| AU (1) | AU2002358874B2 (de) |
| BR (1) | BR0206363A (de) |
| CA (1) | CA2465691C (de) |
| DE (1) | DE60207104T2 (de) |
| DK (1) | DK1446402T3 (de) |
| ES (1) | ES2250731T3 (de) |
| HR (1) | HRP20040401A2 (de) |
| HU (1) | HUP0402038A2 (de) |
| IL (2) | IL161842A0 (de) |
| MA (1) | MA27077A1 (de) |
| MX (1) | MXPA04003766A (de) |
| NO (1) | NO20033130L (de) |
| PL (1) | PL370322A1 (de) |
| RU (1) | RU2004117525A (de) |
| WO (1) | WO2003040142A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2669810A1 (fr) * | 2001-11-09 | 2003-05-15 | Aventis Pharma S.A. | Composes intermediaires pour la preparation de derives de 2-amino-thiazoline |
| KR101052122B1 (ko) | 2005-10-25 | 2011-07-26 | 시오노기세야쿠 가부시키가이샤 | 아미노디히드로티아진 유도체 |
| EP2151435A4 (de) | 2007-04-24 | 2011-09-14 | Shionogi & Co | Pharmazeutische zusammensetzung zur behandlung von morbus alzheimer |
| EP2147914B1 (de) | 2007-04-24 | 2014-06-04 | Shionogi&Co., Ltd. | Mit zyklischen gruppen substituierte aminodihydrothiazin-derivate |
| MX2010013256A (es) | 2008-06-13 | 2010-12-21 | Shionogi & Co | Derivado heterociclico que contiene azufre que tiene actividad inhibitoria de beta-secretasa. |
| JPWO2010047372A1 (ja) | 2008-10-22 | 2012-03-22 | 塩野義製薬株式会社 | Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体 |
| JPWO2011071135A1 (ja) | 2009-12-11 | 2013-04-22 | 塩野義製薬株式会社 | オキサジン誘導体 |
| CA2816285A1 (en) | 2010-10-29 | 2012-05-03 | Shionogi & Co., Ltd. | Naphthyridine derivative |
| EP2634188A4 (de) | 2010-10-29 | 2014-05-07 | Shionogi & Co | Kondensiertes aminodihydropyrimidinderivat |
| TW201247635A (en) | 2011-04-26 | 2012-12-01 | Shionogi & Co | Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them |
| JP2016501827A (ja) | 2012-10-24 | 2016-01-21 | 塩野義製薬株式会社 | Ｂａｃｅ１阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体 |
| CN113456623A (zh) * | 2014-10-24 | 2021-10-01 | 韩国海洋研究院 | 用于预防或治疗神经变性疾病的含有Ramalin的组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08503940A (ja) * | 1992-11-27 | 1996-04-30 | ザ ウエルカム ファウンデーション リミテッド | 酵素阻害薬 |
| EP0724570B1 (de) * | 1993-10-21 | 1999-03-03 | G.D. Searle & Co. | Amidino-derivate als no-synthetase inhibitoren |
| AU4149696A (en) * | 1994-11-15 | 1996-06-06 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
| FR2810037B1 (fr) * | 2000-06-09 | 2004-04-23 | Aventis Pharma Sa | Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible |
-
2002
- 2002-11-07 DE DE60207104T patent/DE60207104T2/de not_active Expired - Lifetime
- 2002-11-07 PL PL02370322A patent/PL370322A1/xx unknown
- 2002-11-07 IL IL16184202A patent/IL161842A0/xx unknown
- 2002-11-07 CA CA2465691A patent/CA2465691C/fr not_active Expired - Fee Related
- 2002-11-07 AT AT02793211T patent/ATE308541T1/de active
- 2002-11-07 JP JP2003542188A patent/JP4365681B2/ja not_active Expired - Fee Related
- 2002-11-07 EP EP02793211A patent/EP1446402B1/de not_active Expired - Lifetime
- 2002-11-07 HU HU0402038A patent/HUP0402038A2/hu unknown
- 2002-11-07 ES ES02793211T patent/ES2250731T3/es not_active Expired - Lifetime
- 2002-11-07 RU RU2004117525/04A patent/RU2004117525A/ru not_active Application Discontinuation
- 2002-11-07 WO PCT/FR2002/003809 patent/WO2003040142A1/fr not_active Ceased
- 2002-11-07 DK DK02793211T patent/DK1446402T3/da active
- 2002-11-07 AU AU2002358874A patent/AU2002358874B2/en not_active Ceased
- 2002-11-07 BR BR0206363-8A patent/BR0206363A/pt not_active Application Discontinuation
- 2002-11-07 MX MXPA04003766A patent/MXPA04003766A/es active IP Right Grant
- 2002-11-07 HR HR20040401A patent/HRP20040401A2/hr not_active Application Discontinuation
- 2002-11-08 US US10/291,110 patent/US6872740B2/en not_active Expired - Fee Related
-
2003
- 2003-07-08 NO NO20033130A patent/NO20033130L/no unknown
-
2004
- 2004-04-22 MA MA27645A patent/MA27077A1/fr unknown
- 2004-05-06 IL IL161842A patent/IL161842A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60207104T2 (de) | 2006-07-13 |
| NO20033130D0 (no) | 2003-07-08 |
| HUP0402038A2 (hu) | 2005-01-28 |
| CA2465691C (fr) | 2011-07-19 |
| DE60207104D1 (de) | 2005-12-08 |
| ES2250731T3 (es) | 2006-04-16 |
| AU2002358874B2 (en) | 2007-09-06 |
| MA27077A1 (fr) | 2004-12-20 |
| DK1446402T3 (da) | 2006-03-06 |
| PL370322A1 (en) | 2005-05-16 |
| EP1446402A1 (de) | 2004-08-18 |
| IL161842A (en) | 2010-12-30 |
| EP1446402B1 (de) | 2005-11-02 |
| CA2465691A1 (fr) | 2003-05-15 |
| RU2004117525A (ru) | 2005-04-20 |
| WO2003040142A1 (fr) | 2003-05-15 |
| NO20033130L (no) | 2003-08-27 |
| JP4365681B2 (ja) | 2009-11-18 |
| US6872740B2 (en) | 2005-03-29 |
| IL161842A0 (en) | 2005-11-20 |
| HRP20040401A2 (en) | 2004-10-31 |
| JP2005509651A (ja) | 2005-04-14 |
| MXPA04003766A (es) | 2004-07-29 |
| US20030225140A1 (en) | 2003-12-04 |
| BR0206363A (pt) | 2003-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2791B1 (en) | Acid secretion inhibitor | |
| ATE478044T1 (de) | Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c | |
| NO20070532L (no) | Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer | |
| NO20070529L (no) | Kinazolindionderivater som parp-inhibitorer | |
| ATE453393T1 (de) | Verwendung von pyridylamiden als angiogenesehemmer | |
| NO20043176L (no) | Nikotinamidderivater nyttige som P38 inhibitorer | |
| DK1218372T3 (da) | Nye heterocykliske forbindelser, der er anvendelige som reversible inhibitorer af cysteinproteaser | |
| ATE432259T1 (de) | Pyridinderivate als dipeptedyl-peptidase-hemmer | |
| ATE449099T1 (de) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
| DE60305061D1 (de) | 2-pyridonderivate als inhibitoren von neutrophiler elastase | |
| NO20071073L (no) | Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
| NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
| MXPA04004037A (es) | Compuestos novedosos de 1, 2, 4-de triazol. | |
| ATE465146T1 (de) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| ATE355265T1 (de) | Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren | |
| ATE308541T1 (de) | 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase | |
| NO20072753L (no) | 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer | |
| ATE399168T1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
| GB0412314D0 (en) | Compounds | |
| ATE348800T1 (de) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| DK1565441T3 (da) | Fremgangsmåde til fremstilling af 2-aminomethylpyridinderivater | |
| ATE399169T1 (de) | Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase | |
| ATE276259T1 (de) | Dihydroporphyrinderivate und ihre verwendung | |
| TW200626130A (en) | 5-membered heterocycle derivatives | |
| NO20081529L (no) | Naftyridinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1446402 Country of ref document: EP |